FREQUENCY OF COMPLIANCE TO GUIDELINE RECOMMENDED TREATMENT IN HEART FAILURE PATIENTS WITH LVEF <40%

Objective: To determine the frequency of compliance to guideline recommended treatment among patients with STAGE-C or STAGE-D heart failure and LVEF<40%. Study Design: Descriptive cross-sectional study. Place and Duration of Study: Adult cardiology department of AFIC/NIHD, Rawalpindi, from...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ammara Avais, Hafiza Sonia Iqbal, Anam Fatima Janjua, Javeria Asghar, Javeria Kamran, Samina Rashid, Erum -Un- Nisa, Naseer Samore, Sohail Aziz
Formato: article
Lenguaje:EN
Publicado: Army Medical College Rawalpindi 2020
Materias:
R
Acceso en línea:https://doaj.org/article/2b6e008c41d045d284a2ad074c3014d1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2b6e008c41d045d284a2ad074c3014d1
record_format dspace
spelling oai:doaj.org-article:2b6e008c41d045d284a2ad074c3014d12021-12-02T14:56:40ZFREQUENCY OF COMPLIANCE TO GUIDELINE RECOMMENDED TREATMENT IN HEART FAILURE PATIENTS WITH LVEF <40%doi.org/10.51253/pafmj.v70iSuppl-4.60220030-96482411-8842https://doaj.org/article/2b6e008c41d045d284a2ad074c3014d12020-12-01T00:00:00Zhttps://pafmj.org/index.php/PAFMJ/article/view/6022https://doaj.org/toc/0030-9648https://doaj.org/toc/2411-8842Objective: To determine the frequency of compliance to guideline recommended treatment among patients with STAGE-C or STAGE-D heart failure and LVEF<40%. Study Design: Descriptive cross-sectional study. Place and Duration of Study: Adult cardiology department of AFIC/NIHD, Rawalpindi, from Sept to Dec 2019. Methodology: Eighty Four patients of Heart Failure with reduced LVEF after satisfying inclusion and exclusion criteria were recruited in this study through non-probability consecutive sampling technique. Data was collected from ER and OPD patients through complete history based on demographics (i.e. age and gender), co-morbidities (i.e. diabetes, hypertension, CAD and smoking history), previous EF record measured on 2D-echo, functional improvement of the patients using NYHA dyspnea class and guideline recommended medication history with compliance. The data was analyzed using SPSS version 23. Results: A total of 84 patients of Heart Failure with LVEF = 31.61 ± 7.61% were enrolled out of whom 62 (73.8%) were male and 22 (26.2%) female patients. The mean age of patients was 62.26 ± 9.879 years. About 30 (35.7%) patients were diabetic, 44 (52.4%) were hypertensive, 19 (22.6%) were current smokers, 16 (19%) were ex-smokers and 49 (58.2%) were nonsmokers. Those with history of CAD were (SVCAD=8 (9.5%), DVCAD=14 (16.7%), TVCAD 15 (17.9%). Compliance of patients to treatment was 74 (88.1%) good. Patients presenting with NYHA Class I/II 3 (3.6%)/20 (23.6%) showed significant improvement after medical therapy 34 (40.5%)/30 (35.7%), whereas those with class III/IV did not show significant improvement in functional status. Conclusion: This survey shows that patient’s compliance is relatively goods but patients with NYHA III/IV were receiving suboptimal treatment. Secondly patients presenting with NYHAI/II after medical therapy showed significant improvement in functional status as compared to those with NYHA III/IV. Thereby further actions are needed for improving quality of life and standard of care among HF patients by optimization of treatment according to guidelines.Ammara AvaisHafiza Sonia IqbalAnam Fatima JanjuaJaveria AsgharJaveria KamranSamina RashidErum -Un- NisaNaseer SamoreSohail AzizArmy Medical College Rawalpindiarticlecoronary artery diseaseleft ventricular ejection fractionnew-york heart associationMedicineRMedicine (General)R5-920ENPakistan Armed Forces Medical Journal, Vol 70, Iss 4, Pp 772-775 (2020)
institution DOAJ
collection DOAJ
language EN
topic coronary artery disease
left ventricular ejection fraction
new-york heart association
Medicine
R
Medicine (General)
R5-920
spellingShingle coronary artery disease
left ventricular ejection fraction
new-york heart association
Medicine
R
Medicine (General)
R5-920
Ammara Avais
Hafiza Sonia Iqbal
Anam Fatima Janjua
Javeria Asghar
Javeria Kamran
Samina Rashid
Erum -Un- Nisa
Naseer Samore
Sohail Aziz
FREQUENCY OF COMPLIANCE TO GUIDELINE RECOMMENDED TREATMENT IN HEART FAILURE PATIENTS WITH LVEF <40%
description Objective: To determine the frequency of compliance to guideline recommended treatment among patients with STAGE-C or STAGE-D heart failure and LVEF<40%. Study Design: Descriptive cross-sectional study. Place and Duration of Study: Adult cardiology department of AFIC/NIHD, Rawalpindi, from Sept to Dec 2019. Methodology: Eighty Four patients of Heart Failure with reduced LVEF after satisfying inclusion and exclusion criteria were recruited in this study through non-probability consecutive sampling technique. Data was collected from ER and OPD patients through complete history based on demographics (i.e. age and gender), co-morbidities (i.e. diabetes, hypertension, CAD and smoking history), previous EF record measured on 2D-echo, functional improvement of the patients using NYHA dyspnea class and guideline recommended medication history with compliance. The data was analyzed using SPSS version 23. Results: A total of 84 patients of Heart Failure with LVEF = 31.61 ± 7.61% were enrolled out of whom 62 (73.8%) were male and 22 (26.2%) female patients. The mean age of patients was 62.26 ± 9.879 years. About 30 (35.7%) patients were diabetic, 44 (52.4%) were hypertensive, 19 (22.6%) were current smokers, 16 (19%) were ex-smokers and 49 (58.2%) were nonsmokers. Those with history of CAD were (SVCAD=8 (9.5%), DVCAD=14 (16.7%), TVCAD 15 (17.9%). Compliance of patients to treatment was 74 (88.1%) good. Patients presenting with NYHA Class I/II 3 (3.6%)/20 (23.6%) showed significant improvement after medical therapy 34 (40.5%)/30 (35.7%), whereas those with class III/IV did not show significant improvement in functional status. Conclusion: This survey shows that patient’s compliance is relatively goods but patients with NYHA III/IV were receiving suboptimal treatment. Secondly patients presenting with NYHAI/II after medical therapy showed significant improvement in functional status as compared to those with NYHA III/IV. Thereby further actions are needed for improving quality of life and standard of care among HF patients by optimization of treatment according to guidelines.
format article
author Ammara Avais
Hafiza Sonia Iqbal
Anam Fatima Janjua
Javeria Asghar
Javeria Kamran
Samina Rashid
Erum -Un- Nisa
Naseer Samore
Sohail Aziz
author_facet Ammara Avais
Hafiza Sonia Iqbal
Anam Fatima Janjua
Javeria Asghar
Javeria Kamran
Samina Rashid
Erum -Un- Nisa
Naseer Samore
Sohail Aziz
author_sort Ammara Avais
title FREQUENCY OF COMPLIANCE TO GUIDELINE RECOMMENDED TREATMENT IN HEART FAILURE PATIENTS WITH LVEF <40%
title_short FREQUENCY OF COMPLIANCE TO GUIDELINE RECOMMENDED TREATMENT IN HEART FAILURE PATIENTS WITH LVEF <40%
title_full FREQUENCY OF COMPLIANCE TO GUIDELINE RECOMMENDED TREATMENT IN HEART FAILURE PATIENTS WITH LVEF <40%
title_fullStr FREQUENCY OF COMPLIANCE TO GUIDELINE RECOMMENDED TREATMENT IN HEART FAILURE PATIENTS WITH LVEF <40%
title_full_unstemmed FREQUENCY OF COMPLIANCE TO GUIDELINE RECOMMENDED TREATMENT IN HEART FAILURE PATIENTS WITH LVEF <40%
title_sort frequency of compliance to guideline recommended treatment in heart failure patients with lvef <40%
publisher Army Medical College Rawalpindi
publishDate 2020
url https://doaj.org/article/2b6e008c41d045d284a2ad074c3014d1
work_keys_str_mv AT ammaraavais frequencyofcompliancetoguidelinerecommendedtreatmentinheartfailurepatientswithlvef40
AT hafizasoniaiqbal frequencyofcompliancetoguidelinerecommendedtreatmentinheartfailurepatientswithlvef40
AT anamfatimajanjua frequencyofcompliancetoguidelinerecommendedtreatmentinheartfailurepatientswithlvef40
AT javeriaasghar frequencyofcompliancetoguidelinerecommendedtreatmentinheartfailurepatientswithlvef40
AT javeriakamran frequencyofcompliancetoguidelinerecommendedtreatmentinheartfailurepatientswithlvef40
AT saminarashid frequencyofcompliancetoguidelinerecommendedtreatmentinheartfailurepatientswithlvef40
AT erumunnisa frequencyofcompliancetoguidelinerecommendedtreatmentinheartfailurepatientswithlvef40
AT naseersamore frequencyofcompliancetoguidelinerecommendedtreatmentinheartfailurepatientswithlvef40
AT sohailaziz frequencyofcompliancetoguidelinerecommendedtreatmentinheartfailurepatientswithlvef40
_version_ 1718389314375647232